Related Experiment Video

Updated: Sep 20, 2026

Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology
03:33

Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology

Published on: May 23, 2025

[Prevalence of Helicobacter pylori infection among patients with multiple sclerosis]

Mieczysław Wender

    Neurologia I Neurochirurgia Polska
    |August 13, 2003
    PubMed

    Insights

    This study found no link between Helicobacter pylori infection and multiple sclerosis (MS) in 90 patients. However, testing for H. pylori is recommended for MS patients undergoing steroid treatment to prevent complications.

    Area of Science:

    • Neurology
    • Gastroenterology
    • Infectious Diseases

    Background:

    • Multiple sclerosis (MS) is a chronic neurological condition.
    • Helicobacter pylori (H. pylori) infection is common globally.
    • The relationship between H. pylori and MS is not well-established.

    Purpose of the Study:

    • To investigate the prevalence of H. pylori antibodies in multiple sclerosis patients.
    • To determine any potential association between H. pylori infection and MS.
    • To assess the clinical relevance of H. pylori screening in MS management.

    Main Methods:

    • Serological Helicotest was used to detect H. pylori antibodies.
    • 90 patients diagnosed with multiple sclerosis were included in the study.
    • Prevalence data were compared to the general population of Poland.

    Main Results:

    • Antibodies against H. pylori were found in 18.9% of MS patients.
    • This prevalence is significantly lower than in the general Polish population.
    • No correlation was observed between H. pylori infection and multiple sclerosis.

    Conclusions:

    • The study suggests no direct link between H. pylori infection and the development of multiple sclerosis.
    • Screening for H. pylori in MS patients is advisable before initiating intensive steroid therapy.
    • Early detection and treatment of H. pylori can mitigate risks of upper gastrointestinal complications during MS relapse management.

    Related Concept Videos

    Multiple Sclerosis l: Introduction01:19

    Multiple Sclerosis l: Introduction

    Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
    Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

    Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

    Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
    Gastritis II: Pathophysiology01:26

    Gastritis II: Pathophysiology

    The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
    Peptic Ulcer01:27

    Peptic Ulcer

    Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
    Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

    Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

    Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
    Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
    Peptic Ulcer Disease I: Introduction01:30

    Peptic Ulcer Disease I: Introduction

    Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
    An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
    Peptic ulcers can also be...